Cited 0 times in Scipus Cited Count

Advances in Amyloid-β Clearance in the Brain and Periphery: Implications for Neurodegenerative Diseases

DC Field Value Language
dc.contributor.authorUllah, R-
dc.contributor.authorLee, EJ-
dc.date.accessioned2023-11-09T05:00:29Z-
dc.date.available2023-11-09T05:00:29Z-
dc.date.issued2023-
dc.identifier.issn1226-2560-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/26503-
dc.description.abstractThis review examines the role of impaired amyloid-β clearance in the accumulation of amyloid-β in the brain and the periphery, which is closely associated with Alzheimer's disease (AD) and cerebral amyloid angiopathy (CAA). The molecular mechanism underlying amyloid-β accumulation is largely unknown, but recent evidence suggests that impaired amyloid-β clearance plays a critical role in its accumulation. The review provides an overview of recent research and proposes strategies for efficient amyloid-β clearance in both the brain and periphery. The clearance of amyloid-β can occur through enzymatic or non-enzymatic pathways in the brain, including neuronal and glial cells, blood-brain barrier, interstitial fluid bulk flow, perivascular drainage, and cerebrospinal fluid absorption-mediated pathways. In the periphery, various mechanisms, including peripheral organs, immunomodulation/immune cells, enzymes, amyloid-β-binding proteins, and amyloid-β-binding cells, are involved in amyloid-β clearance. Although recent findings have shed light on amyloid-β clearance in both regions, opportunities remain in areas where limited data is available. Therefore, future strategies that enhance amyloid-β clearance in the brain and/or periphery, either through central or peripheral clearance approaches or in combination, are highly encouraged. These strategies will provide new insight into the disease pathogenesis at the molecular level and explore new targets for inhibiting amyloid-β deposition, which is central to the pathogenesis of sporadic AD (amyloid-β in parenchyma) and CAA (amyloid-β in blood vessels).-
dc.language.isoen-
dc.titleAdvances in Amyloid-β Clearance in the Brain and Periphery: Implications for Neurodegenerative Diseases-
dc.typeArticle-
dc.identifier.pmid37749925-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569141-
dc.subject.keywordAlzheimer’s disease (AD)-
dc.subject.keywordAmyloid-β clearance-
dc.subject.keywordBrain and periphery-
dc.subject.keywordCerebral amyloid angiopathy (CAA)-
dc.contributor.affiliatedAuthorLee, EJ-
dc.type.localJournal Papers-
dc.identifier.doi10.5607/en23014-
dc.citation.titleExperimental neurobiology-
dc.citation.volume32-
dc.citation.number4-
dc.citation.date2023-
dc.citation.startPage216-
dc.citation.endPage246-
dc.identifier.bibliographicCitationExperimental neurobiology, 32(4). : 216-246, 2023-
dc.identifier.eissn2093-8144-
dc.relation.journalidJ012262560-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Brain Science
Files in This Item:
37749925.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse